$CLDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Celldex Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Celldex Therapeutics, Inc.. Get notifications about new insider transactions in Celldex Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | CLDX | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 28.00 | 224,000 | 6,272,000 | 224,000 | |
Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | M | 2.78 | 9,375 | 26,063 | 20,625 | |
Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | M | 9.02 | 11,457 | 103,302 | 6,876 | |
Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Sell | S | 18.61 | 9,375 | 174,436 | 208 | 9.6 K to 208 (-97.83 %) |
Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Buy | M | 2.78 | 9,375 | 26,063 | 9,583 | 208 to 9.6 K (+4,507.21 %) |
Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Sell | S | 18.61 | 11,457 | 213,175 | 208 | 11.7 K to 208 (-98.22 %) |
Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Buy | M | 9.02 | 11,457 | 103,302 | 11,665 | 208 to 11.7 K (+5,508.17 %) |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Martin Samuel Bates | SVP and CFO | Option Exercise | A | 10.38 | 105,600 | 1,096,128 | 105,600 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Heath-Chiozzi Margo | SVP of Regulatory A ... | Option Exercise | A | 10.38 | 84,000 | 871,920 | 84,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Option Exercise | A | 10.38 | 84,000 | 871,920 | 84,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Crowley Elizabeth | Sr. VP &CPDO | Option Exercise | A | 10.38 | 84,000 | 871,920 | 84,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 10.38 | 14,400 | 149,472 | 14,400 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | A | 10.38 | 42,000 | 435,960 | 42,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Young Diane C. | SVP, Chief Medical ... | Option Exercise | A | 10.38 | 72,000 | 747,360 | 72,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 10.38 | 108,000 | 1,121,040 | 108,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 10.38 | 245,000 | 2,543,100 | 245,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Shoos Karen L. | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
Jun 19 2020 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
Jun 12 2020 | AVAN | Celldex Therapeuti ... | Young Diane C. | SVP, Chief Medical ... | Buy | P | 4.73 | 2,115 | 10,004 | 2,115 | 0 to 2.1 K |
Jun 11 2020 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Buy | P | 4.83 | 1,050 | 5,072 | 1,367 | 317 to 1.4 K (+331.23 %) |
Jun 11 2020 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Buy | P | 4.83 | 1,050 | 5,072 | 1,367 | 317 to 1.4 K (+331.23 %) |
Jun 10 2020 | AVAN | Celldex Therapeuti ... | Heath-Chiozzi Margo | SVP of Regulatory A ... | Buy | P | 3.01 | 1,000 | 3,005 | 1,000 | 0 to 1,000 |
Jun 10 2020 | AVAN | Celldex Therapeuti ... | Martin Samuel Bates | SVP and CFO | Buy | P | 3.05 | 9,750 | 29,738 | 10,735 | 985 to 10.7 K (+989.85 %) |
Jun 10 2020 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Buy | P | 3.00 | 8,305 | 24,915 | 12,704 | 4.4 K to 12.7 K (+188.79 %) |
Jun 10 2020 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Buy | P | 2.99 | 5,000 | 14,954 | 7,357 | 2.4 K to 7.4 K (+212.13 %) |
Jun 10 2020 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.06 | 15,000 | 45,900 | 19,438 | 4.4 K to 19.4 K (+337.99 %) |
Jul 09 2019 | AVAN | Celldex Therapeuti ... | Young Diane C. | SVP, Chief Medical ... | Option Exercise | A | 2.71 | 60,000 | 162,600 | 60,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 2.78 | 11,000 | 30,580 | 11,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | A | 2.78 | 30,000 | 83,400 | 30,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Heath-Chiozzi Margo | SVP of Regulatory A ... | Option Exercise | A | 2.78 | 43,000 | 119,540 | 43,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Crowley Elizabeth | Sr. VP &CPDO | Option Exercise | A | 2.78 | 43,000 | 119,540 | 43,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Option Exercise | A | 2.78 | 43,000 | 119,540 | 43,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Martin Samuel Bates | SVP and CFO | Option Exercise | A | 2.78 | 43,000 | 119,540 | 43,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 2.78 | 60,000 | 166,800 | 60,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 2.78 | 100,000 | 278,000 | 100,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Shoos Karen L. | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
Dec 04 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.30 | 2,824 | 843 | 180,697 | 183.5 K to 180.7 K (-1.54 %) |
Nov 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.31 | 2,888 | 908 | 183,521 | 186.4 K to 183.5 K (-1.55 %) |
Oct 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.45 | 2,888 | 1,302 | 186,409 | 189.3 K to 186.4 K (-1.53 %) |
Sep 05 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.50 | 2,813 | 1,412 | 189,297 | 192.1 K to 189.3 K (-1.46 %) |
Aug 28 2018 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Buy | P | 0.48 | 40,000 | 19,200 | 65,997 | 26 K to 66 K (+153.86 %) |
Aug 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.47 | 2,813 | 1,308 | 192,110 | 194.9 K to 192.1 K (-1.44 %) |
Jul 03 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.50 | 2,813 | 1,417 | 194,923 | 197.7 K to 194.9 K (-1.42 %) |
Jun 18 2018 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Buy | P | 0.59 | 16,500 | 9,783 | 35,368 | 18.9 K to 35.4 K (+87.45 %) |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Heath-Chiozzi Margo | SVP of Regulatory A ... | Option Exercise | A | 0.60 | 275,000 | 165,303 | 275,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Martin Samuel Bates | SVP and CFO | Option Exercise | A | 0.60 | 395,000 | 237,435 | 395,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Option Exercise | A | 0.60 | 275,000 | 165,303 | 275,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Crowley Elizabeth | Sr. VP &CPDO | Option Exercise | A | 0.60 | 300,000 | 180,330 | 300,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | A | 0.60 | 275,000 | 165,303 | 275,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 0.60 | 200,000 | 120,220 | 200,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 0.60 | 390,000 | 234,429 | 390,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 0.60 | 1,075,000 | 646,183 | 1,075,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Shoos Karen L. | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 04 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.58 | 2,813 | 1,632 | 197,736 | 200.5 K to 197.7 K (-1.40 %) |
May 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.74 | 2,813 | 2,082 | 200,549 | 203.4 K to 200.5 K (-1.38 %) |
Apr 03 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.33 | 3,379 | 7,873 | 203,362 | 206.7 K to 203.4 K (-1.63 %) |
Mar 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.25 | 3,415 | 7,684 | 206,741 | 210.2 K to 206.7 K (-1.62 %) |
Feb 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.76 | 3,415 | 9,425 | 210,156 | 213.6 K to 210.2 K (-1.60 %) |
Jan 03 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.84 | 3,665 | 10,409 | 213,571 | 217.2 K to 213.6 K (-1.69 %) |
Dec 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.00 | 3,212 | 9,636 | 217,236 | 220.4 K to 217.2 K (-1.46 %) |
Nov 02 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.44 | 3,212 | 7,837 | 220,448 | 223.7 K to 220.4 K (-1.44 %) |
Oct 03 2017 | AVAN | Celldex Therapeuti ... | Heath-Chiozzi Margo | SVP of Regulatory A ... | Option Exercise | A | 3.01 | 75,000 | 225,750 | 75,000 | |
Oct 02 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.86 | 3,212 | 9,186 | 223,660 | 226.9 K to 223.7 K (-1.42 %) |
Sep 05 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.46 | 3,212 | 7,902 | 226,872 | 230.1 K to 226.9 K (-1.40 %) |
Aug 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.29 | 2,869 | 6,570 | 230,084 | 233 K to 230.1 K (-1.23 %) |
Jul 05 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.47 | 2,869 | 7,086 | 232,953 | 235.8 K to 233 K (-1.22 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.32 | 8,000 | 18,560 | 8,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Grant | A | 0.00 | 10,000 | 0 | 25,997 | 16 K to 26 K (+62.51 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Grant | A | 0.00 | 10,000 | 0 | 235,822 | 225.8 K to 235.8 K (+4.43 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 10,000 | 0 | 38,500 | 28.5 K to 38.5 K (+35.09 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 10,000 | 0 | 41,833 | 31.8 K to 41.8 K (+31.41 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 10,000 | 0 | 41,916 | 31.9 K to 41.9 K (+31.33 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 10,000 | 0 | 73,500 | 63.5 K to 73.5 K (+15.75 %) |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Option Exercise | A | 2.32 | 65,000 | 150,800 | 65,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 2.32 | 67,000 | 155,440 | 67,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | A | 2.32 | 75,000 | 174,000 | 75,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Crowley Elizabeth | Sr. VP &CPDO | Option Exercise | A | 2.32 | 82,000 | 190,240 | 82,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 2.32 | 150,000 | 348,000 | 150,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 2.32 | 162,000 | 375,840 | 162,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 2.32 | 475,000 | 1,102,000 | 475,000 | |
Jun 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.83 | 2,869 | 8,119 | 225,822 | 228.7 K to 225.8 K (-1.25 %) |
May 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.33 | 2,869 | 9,554 | 228,691 | 231.6 K to 228.7 K (-1.24 %) |
Apr 03 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.61 | 2,869 | 10,357 | 231,560 | 234.4 K to 231.6 K (-1.22 %) |
Mar 03 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.54 | 32,927 | 116,562 | 234,429 | 267.4 K to 234.4 K (-12.32 %) |
Mar 01 2017 | AVAN | Celldex Therapeuti ... | MARINO JAMES J | Director | Option Exercise | A | 3.56 | 8,000 | 28,480 | 8,000 | |
Dec 15 2016 | AVAN | Celldex Therapeuti ... | LaVallee Theresa | SVP, Reg.& Precisio ... | Option Exercise | A | 3.72 | 75,000 | 279,000 | 75,000 | |
Dec 15 2016 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Option Exercise | A | 3.72 | 8,000 | 29,760 | 8,000 | |
Sep 07 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 10,000 | 28,000 | 25,000 | |
Sep 07 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 10,000 | 28,000 | 83,586 | 73.6 K to 83.6 K (+13.59 %) |
Sep 06 2016 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Buy | P | 3.32 | 3,000 | 9,960 | 18,868 | 15.9 K to 18.9 K (+18.91 %) |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | A | 4.72 | 75,000 | 354,000 | 75,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 4.72 | 67,000 | 316,240 | 67,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 4.72 | 135,000 | 637,200 | 135,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 4.72 | 157,000 | 741,040 | 157,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 4.72 | 162,000 | 764,640 | 162,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 4.72 | 475,000 | 2,242,000 | 475,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | van den Broek Richard | Director | Option Exercise | A | 4.72 | 15,000 | 70,800 | 15,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | van den Broek Richard | Director | Grant | A | 0.00 | 10,000 | 0 | 233,500 | 223.5 K to 233.5 K (+4.47 %) |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | Elston George | Director | Option Exercise | A | 4.72 | 15,000 | 70,800 | 15,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 10,000 | 0 | 28,500 | 18.5 K to 28.5 K (+54.05 %) |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Option Exercise | A | 4.72 | 15,000 | 70,800 | 15,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 10,000 | 0 | 31,833 | 21.8 K to 31.8 K (+45.80 %) |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 4.72 | 15,000 | 70,800 | 15,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 10,000 | 0 | 28,500 | 18.5 K to 28.5 K (+54.05 %) |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 4.72 | 15,000 | 70,800 | 15,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 10,000 | 0 | 31,916 | 21.9 K to 31.9 K (+45.63 %) |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | A | 4.72 | 15,000 | 70,800 | 15,000 | |
Jun 09 2016 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 10,000 | 0 | 63,500 | 53.5 K to 63.5 K (+18.69 %) |
Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 2,847 | 12,812 | 5,000 | |
Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 2,847 | 12,812 | 73,586 | 70.7 K to 73.6 K (+4.02 %) |
Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 20,000 | 56,000 | 70,739 | 50.7 K to 70.7 K (+39.42 %) |
Mar 10 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 15,000 | 42,000 | 20,000 | |
Mar 10 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 15,000 | 42,000 | 50,739 | 35.7 K to 50.7 K (+41.97 %) |
Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.52 | 25,000 | 213,000 | 0 | |
Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 18.00 | 25,000 | 450,000 | 35,109 | 60.1 K to 35.1 K (-41.59 %) |
Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.52 | 25,000 | 213,000 | 60,109 | 35.1 K to 60.1 K (+71.21 %) |
Sep 14 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 10,000 | 45,000 | 7,847 | |
Sep 14 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 10,000 | 45,000 | 35,109 | 25.1 K to 35.1 K (+39.83 %) |
Aug 26 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 14.00 | 5,000 | 70,000 | 53,500 | 48.5 K to 53.5 K (+10.31 %) |
Aug 21 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 15.00 | 5,000 | 75,000 | 48,500 | 43.5 K to 48.5 K (+11.49 %) |
Aug 19 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 15.96 | 2,500 | 39,900 | 43,500 | 41 K to 43.5 K (+6.10 %) |
Aug 19 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 15.94 | 2,200 | 35,068 | 41,000 | 38.8 K to 41 K (+5.67 %) |
Aug 19 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 15.93 | 300 | 4,779 | 38,800 | 38.5 K to 38.8 K (+0.78 %) |
Aug 14 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 16.59 | 5,000 | 82,950 | 38,500 | 33.5 K to 38.5 K (+14.93 %) |
Aug 14 2015 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President and CEO | Buy | P | 16.81 | 5,800 | 97,497 | 50,028 | 44.2 K to 50 K (+13.11 %) |
Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.52 | 25,000 | 213,000 | 0 | |
Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 24.59 | 25,000 | 614,753 | 24,609 | 49.6 K to 24.6 K (-50.39 %) |
Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.52 | 25,000 | 213,000 | 49,609 | 24.6 K to 49.6 K (+101.59 %) |